Vnitr Lek 2021, 67(1):58-61 | DOI: 10.36290/vnl.2021.009

Overlap syndrome SLE - ANCA associated vasculitis

Martina Skácelová1, Pavel Horák1, Jana Janková2
1 III. interní klinika - nefrologická, revmatologická a endokrinologická, FN a LF UP Olomouc
2 Ústav klinické a molekulární patologie, LF UP Olomouc

Incidence of ANCA antibodies in patients with systemic lupus erythematosus (SLE) is described in 24-31 %, but they are not related to the distribution and severity of organ involvement in SLE; the routine monitoring is not recommended. Overlap syndrome of systemic lupus erythematosus and ANCA associated vasculitis (AAV) is rare. The difficult diagnosis and treatment of this syndrome is described in this case report of the patient with SLE and severe kidney involvement resulting from AAV.

Keywords: ANCA associated vasculitis, overlap syndrome, systemic lupus erythematosus.

Published: March 2, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Skácelová M, Horák P, Janková J. Overlap syndrome SLE - ANCA associated vasculitis. Vnitr Lek. 2021;67(1):58-61. doi: 10.36290/vnl.2021.009.
Download citation

References

  1. Devrimsel G, Serdaroglu Beyazal M. Three Case Reports of Rhupus Syndrome: An Overlap Syndrome of Rheumatoid Arthritis and Systemic Lupus Erythematosus. Case Rep Rheumatol. 2018;2018:6194738. Published 2018 Jan 21. doi: 10.1155/2018/6194738 Go to original source... Go to PubMed...
  2. AlFadhli S., Nizam R. Rhupus: a crosswalk between lupus and rheumatoid arthritis. OA Arthritis. 2014; 2(1): p. 3.
  3. Lockshin MD, Levine AB, Erkan D. Patients with overlap autoimmunedisease differ from those with'pure' disease. Lupus Science & Medicine 2015; 2: e000084. doi: 10.1136/lupus-2015-000084. Go to original source... Go to PubMed...
  4. Jarrot PA, Chiche L, Hervier B et al. Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antibody‑Associated Vasculitis Overlap Syndrome in Patients With Biopsy‑Proven Glomerulonephritis. Medicine (Baltimore).2016; 95(22): e3748. doi: 10.1097/MD.0000000000003748. Go to original source... Go to PubMed...
  5. Hervier B, Hamidou M, Haroche J et al. Systemic lupus erythematosus associated with ANCA‑associated vasculitis: an overlapping syndrome? Rheumatol Int. 2012 Oct; 32(10): 3285-3290. Epub 2011 Jul 30. Go to original source... Go to PubMed...
  6. Farshad S, Kanaan C, Savedchuk S et al. Systemic Lupus Erythematosus (SLE) with Acute Nephritis, Antineutrophil Cytoplasmic Antibody- (ANCA-) Associated Vasculitis, and Thrombotic Thrombocytopenic Purpura (TTP): A Rare Case Report with Literature Review. Case Rep Rheumatol. 2019 Dec 14; 2019: 8750306. doi: 10.1155/2019/8750306. eCollection 2019. Go to original source...
  7. Petri M, Orbai AM, Alarcón GS et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012; 64(8): 2677-2686. doi: 10.1002/art.34473. Go to original source... Go to PubMed...
  8. Aringer M, Costenbader K, Daikh D et al. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019; 71(9): 1400-1412. doi: 10.1002/art.40930. Epub 2019 Aug 6. Go to original source... Go to PubMed...
  9. Merkel PA, Polisson RP, Chang Y et al. Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med. 1997; 126(11): 866-873. Go to original source... Go to PubMed...
  10. Fauzi AR, Kong NC, Chua MK et al. Antibodies in systemic lupus antineutrophil cytoplasmic erythematosus: prevalence, disease activity correlations and organ system associations. Med J Malaysia. 2004; 59(3): 372-377. Go to PubMed...
  11. Pradhan VD, Badakere SS, Bichile LS et al. Anti‑neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. J Assoc Physicians India. 2004; 52: 533-537. Go to PubMed...
  12. Olson SW, Lee JJ, Poirier M et al. Anti‑Myeloperoxidase Antibodies Associate with Future Proliferative Lupus Nephritis. Autoimmune, DiS. 2017; 2017: 1872846. doi: 10.1155/2017/1872846. Epub 2017 Dec 24. Go to original source... Go to PubMed...
  13. Wang S, Shang J, Xiao J et al. Clinicopathologic characteristics and outcomes of lupus nephritis with positive antineutrophil cytoplasmic antibody. Ren Fail. 2020; 42(1): 244-254. doi: 10.1080/0886022X.2020.1735416. Go to original source... Go to PubMed...
  14. Koh JH, Kemna MJ, Cohen Tervaert JW et al. Can an increase in anti‑neutrophil cytoplasmic autoantibody titer predict relapses in anti‑neutrophil cytoplasmic antibody associated vasculitis? Arthritis Rheum 2016; 68: 1571-1573. Go to original source... Go to PubMed...
  15. Kitching AR, Anders HJ, Basu N et al. ANCA‑associated vasculitis. Nat Rev Dis Primers. 2020; 6(1): 71. Published 2020 Aug 27. doi:10.1038/s41572-020-0204-y Go to original source... Go to PubMed...
  16. Jesmin T, Roy RR, Anjum MF, Akter M. Anti‑neutrophil cytoplasmic antibodies in systemic lupus erythematosus and lupus nephritis: an overlapping syndrome. IOSR Journal of Dental and Medical Sciences. 2017; 16(3): 6-8. doi: 10.9790/0853-1603050608. Go to original source...
  17. Farah RI, Shahin NA, Alawneh M, Adwan M. Rapidly progressive glomerulonephritis due to systemic lupus erythematosus and ANCA‑associated vasculitis overlap. Lupus. 2020; 29(8): 983-986.
  18. Itikyala S, Pattanaik D, Raza S. Systemic Lupus Erythematosus (SLE) and Antineutrophil Cytoplasmic Antibody‑Associated Vasculitis (AAV) Overlap Syndrome: Case Report and Review of the Literature. Case Rep Rheumatol. 2019; 2019: 5013904. doi: 10.1155/2019/5013904. eCollection 2019. Go to original source... Go to PubMed...
  19. Curtiss P, Liebman T, Khorolsky C, Brinster N, Beasley J, Lo Sicco K. Systemic lupus erythematosus and antineutrophil cytoplasmic antibody‑associated vasculitis: an emerging overlap syndrome with cutaneous manifestations.Fanouriakis A, Kostopoulou M, Alunno A et al 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Annals of the Rheumatic Diseases 2019; 78: 736-745. Go to original source... Go to PubMed...
  20. Yates M, Watts RA, Bajema IM et al EULAR/ERA‑EDTA recommendations for the management of ANCA‑associated vasculitis Annals of the Rheumatic Diseases 2016; 75: 1583-1594. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.